Early Access — free while we kick the tires
EdgarHawk

ANEB Anebulo Pharmaceuticals, Inc. Insider Trading

1 filing analyzed · Latest 2024-12-26
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
December 2024
2024-12-26
high
English Aron R. Buy
10,101,010 shares
$10,000,000
@ $0.99
Significance 8/10

Director Aron R. English purchases 10,101,010 shares (10.10M) of ANEB at $0.99 for $9,999,999.90, raising stake 188.2%

Director English deployed approximately $10.0M to purchase 10,101,010 shares at $0.99, tripling his holdings from 5,366,290 to 15,467,300 shares—a net change of +188.2%. This represents a material open-market commitment at a price near the 52-week low of $0.99, during a period when the stock is down 48.1% from its 52-week high of $3.12. However, the context demands caution: the company reported a net loss of $-2,200,736.00 over its most recent full fiscal year, and the director's own cross-ticker track record shows modest results with an average 90-day return of +4.0% across 20 prior buys (53.85% win rate). The timing and scale of this purchase warrant investor scrutiny given the company's unprofitable state and the director's historical performance profile, which shows near-break-even average 30-day returns at -2.7%.

Insiders here also file at

Get alerts for ANEB

Add ANEB to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access